Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Echinacea angustifolia is a species of the Echinacea genus, commonly known as a medicinal herb in North America and one of the three primary Echinacea species used in herbal medicine, alongside Echinacea purpurea and Echinacea pallida.[1][3] Traditionally, Native Americans used it to treat a variety of ailments including respiratory infections and snakebites, later becoming popular as a general immunostimulant, particularly for the prevention and treatment of the common cold and influenza.[3] Primary *active constituents* include cichoric acid, caftaric acid, polysaccharides (such as heteroxylan and arabinogalactan), and alkylamides.[1][3] Mechanistically, echinacea angustifolia is believed to *enhance immune function* by upregulating interleukin-2 and IL-8, downregulating TNF-alpha and IL-6, stimulating phagocytosis, activating macrophages and lymphocytes to secrete TNF and IL-1, and enhancing natural killer cell activity.[1][3] It may also exert anti-inflammatory effects and has shown potential antiviral and wound-healing activities in preclinical models.[1] Common usage forms include root and aerial part extracts, available as capsules, tablets, liquid extracts, and teas.[2][3] Clinical data on efficacy for respiratory infections are mixed; some studies show a modest reduction in severity or duration of symptoms, while others find no effect.[1][3] Echinacea angustifolia is not approved by the FDA as a medicinal drug but is widely used as a dietary supplement.[2]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on echinacea angustifolia.